Michael Wayne Kalb insider trades

Open-market stock purchases and sales by Michael Wayne Kalb, Executive Vice President & CFO at Catalyst Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 1, 2016.

Recent trades

DateStockTradeValue
Jan 5, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jan 5, 2026CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 21, 2025CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Nov 21, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 20, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 20, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—

Companies traded

  • CPRX Catalyst Pharmaceuticals, Inc: other filings, last Jan 5, 2026
  • IMPL Impel Pharmaceuticals Inc: other filings, last May 10, 2023
  • CINC CinCor Pharma, Inc: other filings, last Feb 24, 2023
  • AMRN Amarin Corp Plc\uk: 14 sales, last Aug 1, 2022

Get free alerts when Michael Wayne Kalb files a new trade →